These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3880764)
1. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. Zweibaum A; Pinto M; Chevalier G; Dussaulx E; Triadou N; Lacroix B; Haffen K; Brun JL; Rousset M J Cell Physiol; 1985 Jan; 122(1):21-9. PubMed ID: 3880764 [TBL] [Abstract][Full Text] [Related]
2. A and H blood group antigens as markers of sucrase-isomaltase from the enterocyte-like differentiated human colon carcinoma cell lines HT-29 and Caco-2. Chantret I; Chevalier G; Dussaulx E; Zweibaum A Cancer Res; 1987 Mar; 47(5):1426-33. PubMed ID: 2434217 [TBL] [Abstract][Full Text] [Related]
3. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Chantret I; Barbat A; Dussaulx E; Brattain MG; Zweibaum A Cancer Res; 1988 Apr; 48(7):1936-42. PubMed ID: 3349466 [TBL] [Abstract][Full Text] [Related]
4. Processing of asparagine-linked oligosaccharides is an early biochemical marker of the enterocytic differentiation of HT-29 cells. Ogier-Denis E; Bauvy C; Aubery M; Codogno P; Sapin C; Rousset M; Zweibaum A; Trugnan G J Cell Biochem; 1989 Sep; 41(1):13-23. PubMed ID: 2592437 [TBL] [Abstract][Full Text] [Related]
5. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Lesuffleur T; Barbat A; Dussaulx E; Zweibaum A Cancer Res; 1990 Oct; 50(19):6334-43. PubMed ID: 2205381 [TBL] [Abstract][Full Text] [Related]
6. Differences in lipid characteristics of undifferentiated and enterocytic-differentiated HT29 human colonic cells. Reynier M; Sari H; d'Anglebermes M; Kye EA; Pasero L Cancer Res; 1991 Feb; 51(4):1270-7. PubMed ID: 1671756 [TBL] [Abstract][Full Text] [Related]
7. Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. Rousset M; Laburthe M; Pinto M; Chevalier G; Rouyer-Fessard C; Dussaulx E; Trugnan G; Boige N; Brun JL; Zweibaum A J Cell Physiol; 1985 Jun; 123(3):377-85. PubMed ID: 2985631 [TBL] [Abstract][Full Text] [Related]
8. Cell polarity regulates the release of secretory component, the epithelial receptor for polymeric immunoglobulins, from the surface of HT-29 colon carcinoma cells. Chintalacharuvu KR; Piskurich JF; Lamm ME; Kaetzel CS J Cell Physiol; 1991 Jul; 148(1):35-47. PubMed ID: 1650373 [TBL] [Abstract][Full Text] [Related]
9. Assembly and functional analysis of tight junction in a colon adenocarcinoma cell line: effect of glucose depletion. Ancillotti R; Goto-Silva L; Montesano G; Oliveira S; Redondo PA; Barbosa LA; De Souza W; Morgado-Díaz JA Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):113-22. PubMed ID: 12839342 [TBL] [Abstract][Full Text] [Related]
10. [Alteration of phenotype, morphology and drug sensitivity in colon cancer cell lines under various culture conditions]. Sakamoto J; Watanabe T; Akiyama S; Morimoto T; Murayama H; Takagi H; Nakazato H Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1864-73. PubMed ID: 2730080 [TBL] [Abstract][Full Text] [Related]
11. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708 [TBL] [Abstract][Full Text] [Related]
12. Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29. Laboisse CL; Maoret JJ; Triadou N; Augeron C Cancer Res; 1988 May; 48(9):2498-504. PubMed ID: 3281752 [TBL] [Abstract][Full Text] [Related]
13. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20. Couvineau A; Maoret JJ; Rouyer-Fessard C; Carrero I; Laburthe M Biochem J; 2000 May; 347 Pt 3(Pt 3):623-32. PubMed ID: 10769164 [TBL] [Abstract][Full Text] [Related]
14. N-glycosylation modification of proteins is an early marker of the enterocytic differentiation process of HT-29 cells. Ogier-Denis E; Bauvy C; Aubery M; Codogno P; Sapin C; Darmoul D; Zweibaum A; Trugnan G Reprod Nutr Dev; 1990; 30(3):325-30. PubMed ID: 2397029 [TBL] [Abstract][Full Text] [Related]
15. Expression of receptors for enterotoxigenic Escherichia coli during enterocytic differentiation of human polarized intestinal epithelial cells in culture. Kernéis S; Chauvière G; Darfeuille-Michaud A; Aubel D; Coconnier MH; Joly B; Servin AL Infect Immun; 1992 Jul; 60(7):2572-80. PubMed ID: 1319401 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of HT-29 human colonic adenocarcinoma cells correlates with increased expression of mitochondrial RNA: effects of trehalose on cell growth and maturation. Lu X; Walker T; MacManus JP; Seligy VL Cancer Res; 1992 Jul; 52(13):3718-25. PubMed ID: 1377597 [TBL] [Abstract][Full Text] [Related]
17. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates. Yang GY; Shamsuddin AM Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811 [TBL] [Abstract][Full Text] [Related]
18. Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells. Rousset M; Paris H; Chevalier G; Terrain B; Murat JC; Zweibaum A Cancer Res; 1984 Jan; 44(1):154-60. PubMed ID: 6418376 [TBL] [Abstract][Full Text] [Related]
19. [Differentiation of human colon cancer cells: a new approach to cancer of the colon]. Zweibaum A Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):257-61; discussion 261-2. PubMed ID: 8250521 [TBL] [Abstract][Full Text] [Related]
20. Expression and posttranslational fate of cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. Isidoro C; De Stefanis D; Démoz M; Ogier-Denis E; Codogno P; Baccino FM Cell Growth Differ; 1997 Sep; 8(9):1029-37. PubMed ID: 9300184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]